The company expired its plan on November 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
53.19 CNY | -1.34% | +3.68% | -3.26% |
Apr. 29 | Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.26% | 4.28B | |
+12.75% | 28.06B | |
+14.59% | 1.81B | |
-2.64% | 697M | |
-9.24% | 474M | |
-81.65% | 216M | |
-15.14% | 108M |
- Stock Market
- Equities
- 688065 Stock
- News Cathay Biotech Inc.
- Cathay Biotech Inc.'s Equity Buyback announced on March 30, 2022, has expired with 1,133,035 shares, representing 0.19% for CNY 94.57 million.